Irampanel
File:Irampanel.svg | |
Systematic (IUPAC) name | |
---|---|
N,N-Dimethyl-2-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)phenoxy]ethanamine
|
|
Identifiers | |
CAS Number | 206260-33-5 |
ATC code | None |
PubChem | CID: 3038472 |
ChemSpider | 2302037 |
ChEMBL | CHEMBL29741 |
Chemical data | |
Formula | C18H19N3O2 |
Molecular mass | 309.362 g/mol |
|
|
|
|
Irampanel (INN, code name BIIR-561) is a drug which acts as a dual noncompetitive antagonist of the AMPA receptor and neuronal voltage-gated sodium channel blocker.[1][2] It was under development by Boehringer Ingelheim for the treatment of acute stroke/cerebral ischemia but never completed clinical trials for this indication.[3][4] Irampanel was also trialed, originally, for the treatment of epilepsy and pain, but these indications, too, were abandoned,[1] and the drug was ultimately never marketed.
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
GABAergics | |||||||||
---|---|---|---|---|---|---|---|---|---|
Channelergics | |||||||||
Others |
|
||||||||
|
Receptor (ligands) |
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (blockers) |
|
||||||||||||||||||||||
Enzyme (inhibitors) |
|
||||||||||||||||||||||
Others | |||||||||||||||||||||||
<templatestyles src="Asbox/styles.css"></templatestyles>
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- Pages with reference errors
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- AMPA receptor antagonists
- Anticonvulsants
- Neuroprotective agents
- Oxadiazoles
- Sodium channel blockers
- Nervous system drug stubs